BioRestorative Therapies, Inc
Price
FilingsNewest: 8-K, Director or officer changeSep 11 →InsidersNo open-market buys or sales.→HoldersJane Street 3.2%XTX Topco 1.1%Citadel 1.1%→Financing →PeersClosest companies: CELZ, BCDA, KTTA→
From the filings
Figures
- Revenue
- $357,870last 12 months
- Net income
- −$11.1Mlast 12 months
- Operating cash flow
- −$11.8Mlast 12 months
- Cash and equivalents
- $3.1Mat the last balance sheet
- Shares outstanding
- 25.5M shareson issue